
Gut Microbe Enhances Effectiveness of Cancer Immunotherapy
A newly isolated gut bacterium, YB328, enhances the effectiveness of PD-1 blockade immunotherapy by promoting dendritic cell migration and activating T cells, leading to improved cancer treatment responses across various tumor types, as demonstrated in patient samples and mouse models.
